Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    Is Neil Woodford a fool to continue pumping money into Capita plc and AstraZeneca plc?

    | G A Chester

    Are Capita plc (LON:CPI) and AstraZeneca plc (LON:AZN) poor investments today?

    Read more »

    Investing Articles

    3 top picks for a 2017 starter portfolio

    | Alan Oscroft

    Here are three shares that could make a great start to your investing career.

    Read more »

    Investing Articles

    Will Vectura Group plc outperform AstraZeneca plc after today’s results gain a Brexit boost?

    | Peter Stephens

    Is Vectura Group plc (LON: VEC) a more attractive buy than healthcare peer AstraZeneca plc (LON: AZN)?

    Read more »

    Investing Articles

    Is Neil Woodford’s favourite stock set to outperform in 2017?

    | Rupert Hargreaves

    Neil Woodford loves this company, but should you be buying?

    Read more »

    Investing Articles

    2 healthcare stocks that could make you rich in 2017

    | Peter Stephens

    These two companies offer bright futures at fair valuations.

    Read more »

    Investing Articles

    My 3 top dividend stocks for Christmas

    | Alan Oscroft

    Tucking away some tasty dividends for Christmas can help you to a prosperous New Year.

    Read more »

    Investing Articles

    Why Eco Animal Health Group Plc is set to outperform AstraZeneca plc in 2017

    | Peter Stephens

    Eco Animal Health Group Plc (LON: EAH) has more appeal than AstraZeneca plc (LON: EAH).

    Read more »

    Investing Articles

    Why I believe these 3 stocks will struggle in 2017

    | Rupert Hargreaves

    These three companies are in danger of generating losses for investors next year.

    Read more »

    Investing Articles

    3 cheap blue chips for December

    | Paul Summers

    Are these Footsie favourites now unmissable bargains?

    Read more »

    Investing Articles

    4 dividend stocks to put on your 2017 shopping list

    | Royston Wild

    Royston Wild reveals a cluster of London stocks with exceptional dividend potential.

    Read more »

    Investing Articles

    Is ReNeuron Group plc a better buy than AstraZeneca plc?

    | Peter Stephens

    Should you ditch AstraZeneca plc (LON: AZN) in favour of ReNeuron Group plc (LON: RENE)?

    Read more »

    Investing Articles

    These 3 FTSE 100 stocks are ridiculously cheap!

    | Royston Wild

    Royston Wild discusses three FTSE 100 (INDEXFTSE: UKX) dealing at rock-bottom prices.

    Read more »